Continuous Quality Improvement Cohorts on Advanced Access

Sponsor
Université de Sherbrooke (Other)
Overall Status
Recruiting
CT.gov ID
NCT05715151
Collaborator
Isabelle Gaboury (Other), Mike Green (Other), Tara Kiran (Other), Janusz Kaczorowski (Other), Maude Laberge (Other)
48
18
2
32.3
2.7
0.1

Study Details

Study Description

Brief Summary

The goal of this clinical trial is to compare the implementation and effects of CQI cohorts on AA for PHC clinics. The main questions it aims to answer are to assess the effectiveness of CQI cohorts on AA outcomes.

Condition or Disease Intervention/Treatment Phase
  • Other: CQI intervention
  • Other: Audit and Feedback
N/A

Detailed Description

SIGNIFICANCE AND PURPOSE: Timely access to primary healthcare is one cornerstone of strong primary healthcare. Across Canada, timely access remains a significant challenge. One of the most highly recommended models around the world to improve timely access is advanced access (AA). Over the last two decades, AA has become increasingly popular in Canada. AA model has been widely promoted by the College of Family Physicians of Canada and several other provincial organizations and professional associations. Some tools to support the implementation of AA to PHC providers and practices have been developed such as workbook by Health Quality Ontario and Doctor of BC. However, those tools are important assets to initiate a reflection to improve, they are often not sufficient. Eight PHC teams interested in improving and expanding the implementation of AA have been coached through several PDSA cycles. However, the personalized support model used is very demanding in terms of capacity and resources. These findings guided the research team in developing and evaluating a Continuous Quality Improvement (CQI) Cohort program on advanced access to support Primary healthcare (PHC) teams.This study aims to develop knowledge on an externally facilitated CQI pan-Canadian cohort program that could potentially be transferred to provincial organizations or professional associations wishing to support clinics in quality improvement projects.

OBJECTIVE: Assess the effectiveness of CQI cohorts on AA outcomes.

QI INTERVENTION PROGRAM: PHC teams will participate in an externally facilitated CQI program focusing on AA. The proposed program consists of cycle of three key activities; 1) Interprofessional reflective sessions and need prioritization, 2) Group mentoring and PDSA Cycles and 3) Cohort cross-learning exchange opportunities.

METHODS: This study will be based on the cluster-controlled trial of a CQI program of PHC teams on AA. 48 PHC teams from Quebec will participate to the externally facilitated CQI cohort intervention. Volunteer clinics from the intervention regions will receive the CQI intervention for 18 months. Intervention clinics will be matched to PHC clinics located in other regions to compose the control group. The match will be based on the clinic level (1 to 10, based on the number of patients registered and services offered. Clinics in the control group will receive an audit on a selection of AA indicators and will be offered the intervention 12 to 18 months following their recruitment. Data collection and analysis will include quantitative data based on a comprehensive assessment of both AA processes and outcomes. These will be measured through a self-reflective survey for PHC team members, EMR data and patients related outcomes questionnaire on access. Qualitative data based on semi-structured interviews with key stakeholders, observations of the CQI activities and analysis of plans of action of documents plan of action will take place.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
48 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Impact of Externally Facilitated Continuous Quality Improvement Cohorts on Advanced Access to Support Primary Healthcare Teams
Actual Study Start Date :
Sep 21, 2022
Anticipated Primary Completion Date :
Jun 1, 2024
Anticipated Study Completion Date :
Jun 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: CQI intervention

The proposed CQI cohort consists of three activities carried out iteratively until the improvement objectives are achieved.

Other: CQI intervention
Activity 1: Reflective sessions and problem prioritisation. Activity 2: PDSA cycles. Activity 3: Group mentoring.

Active Comparator: Audit and feedback

Clinics in the control group will receive feedback on six key AA indicators, patients reported experience about access and selected AA processes.

Other: Audit and Feedback
Audit and Feedback on six key AA indicators, patients reported experience about access and selected AA processes.

Outcome Measures

Primary Outcome Measures

  1. 3rd next available appointment (weekly) [18 month]

    Delay before the 3rd next available appointment. The 3rd next available appointment is used (rather than the 1st or 2nd) to decrease variation.

  2. Percent of relational continuity (monthly) [18 month]

    Total number of medical consultations with a patient's attached family physician (or specialised nurse) out of the total number of consultations with any family physician (or specialised nurse) from the clinic. Evaluates relational continuity between the provider and their registered patients.

Secondary Outcome Measures

  1. Percent of 48-hour open slots (weekly) [18 month]

    Proportion of appointments available in the next 48 hours. Provides an overview of the provider's ability to respond to urgent care demands.

  2. Use of walk-in (monthly) [18 month]

    Proportion of walk-in visits by registered patients to each professional.

  3. Proportion of multidisciplinary involvement (monthly) [18 month]

    Evaluates the proportion of involvement of different types of providers (social workers, nurses, pharmacists, etc.) with registered patients.

  4. Discontinuity for chronic patients (monthly) [18 month]

    Proportion of chronic patients without any consultations within the last 12 months.

  5. 3rd next available appointment (weekly) [12 month]

    Delay before the 3rd next available appointment. The 3rd next available appointment is used (rather than the 1st or 2nd) to decrease variation.

  6. Percent of relational continuity (monthly) [12 month]

    Total number of medical consultations with a patient's attached family physician (or specialised nurse) out of the total number of consultations with any family physician (or specialised nurse) from the clinic. Evaluates relational continuity between the provider and their registered patients.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion criteria:
  • Clinics must offer interprofessional care.

  • At least 50 % of all team members should accept to take part in the study.

Exclusion criteria:
  • Solo Practice Physicians

  • Physician-nurse only model

Contacts and Locations

Locations

Site City State Country Postal Code
1 CISSS de la Gaspésie Gaspé Quebec Canada
2 CISSS de l'Outaouais Gatineau Quebec Canada J8T 4J3
3 CISSS de Lanaudière Joliette Quebec Canada
4 CISSS de Laval Laval Quebec Canada
5 CIUSSS de Montérégie-Centre Longueuil Quebec Canada
6 CISSS de Chaudière-Appalaches Lévis Quebec Canada
7 CIUSSS de l'Est-de-l'Île-de-Montréal Montréal Quebec Canada H1T 2M4
8 CIUSSS de l'Ouest-de-l'Île-de-Montréal Montréal Quebec Canada
9 CIUSSS du Centre-Ouest-de-l'Île-de-Montréal Montréal Quebec Canada
10 CIUSSS du Centre-Sud-de-l'Île-de-Montréal Montréal Quebec Canada
11 CIUSSS du Nord-de-l'Île-de-Montréal Montréal Quebec Canada
12 CISSS de l'Abitibi-Témiscamingue Rouyn-Noranda Quebec Canada J9X 2A9
13 CISSS de la Montérégie-Ouest Saint-Hubert Quebec Canada J3Y 6W9
14 CISSS de la Montérégie-Est Saint-Hyacinthe Quebec Canada J2S 4Y8
15 CISSS des Laurentides Saint-Jérôme Quebec Canada
16 CIUSSS de l'Estrie-CHUS Sherbrooke Quebec Canada
17 CIUSSS de la Mauricie et Centre-du-Québec Trois-Rivières Quebec Canada
18 CIUSSS de la Capitale-Nationale Québec Canada G1M 3X7

Sponsors and Collaborators

  • Université de Sherbrooke
  • Isabelle Gaboury
  • Mike Green
  • Tara Kiran
  • Janusz Kaczorowski
  • Maude Laberge

Investigators

  • Principal Investigator: Mylaine Breton, PhD, Université de Sherbrooke

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Mylaine Breton, Associate Professor, Department of Community Health Sciences, Université de Sherbrooke
ClinicalTrials.gov Identifier:
NCT05715151
Other Study ID Numbers:
  • MP-04-2022-696
First Posted:
Feb 6, 2023
Last Update Posted:
Feb 6, 2023
Last Verified:
Feb 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Mylaine Breton, Associate Professor, Department of Community Health Sciences, Université de Sherbrooke

Study Results

No Results Posted as of Feb 6, 2023